CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Adults Undergoing Double Cord Blood Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01300611
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:55.292818+00:00
Published At: 2020-12-08T00:00:00+00:00
Record Updated At: 2020-12-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Double Cord Blood Transplant", "Acute Myelogenous Leukemia", "Myelodysplastic Syndrome", "Myelofibrosis", "Acute Lymphoblastic Leukemia", "Chronic Myelocytic Leukemia", "Non Hodgkins Lymphoma", "Hodgkins Lymphoma", "Chronic Lymphocytic Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-12-08"
protocolSection.identificationModule.nctId: "NCT01300611"
protocolSection.identificationModule.officialTitle: "Phase I Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Adults Undergoing Double Cord Blood Transplantation"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.